- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma oxylipin profiles reflect Parkinson's disease stage
Authors
Keywords
-
Journal
PROSTAGLANDINS & OTHER LIPID MEDIATORS
Volume -, Issue -, Pages 106788
Publisher
Elsevier BV
Online
2023-10-20
DOI
10.1016/j.prostaglandins.2023.106788
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson’s disease
- (2022) Elodie Kip et al. AGEING RESEARCH REVIEWS
- Overlap between Central and Peripheral Transcriptomes in Parkinson’s Disease but Not Alzheimer’s Disease
- (2022) Kosar Hooshmand et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?
- (2022) Valerio Chiurchiù et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multi-Omics Approach Points to the Importance of Oxylipins Metabolism in Early-Stage Breast Cancer
- (2022) Dmitry V. Chistyakov et al. Cancers
- HPLC-MS/MS Oxylipin Analysis of Plasma from Amyotrophic Lateral Sclerosis Patients
- (2022) Mauricio Mastrogiovanni et al. Biomedicines
- Investigation of the Role of PUFA Metabolism in Breast Cancer Using a Rank-Based Random Forest Algorithm
- (2022) Mariia V. Guryleva et al. Cancers
- MIND and Mediterranean Diets Associated with Later Onset of Parkinson's Disease
- (2021) Avril Metcalfe‐Roach et al. MOVEMENT DISORDERS
- Oxolipidomics profile in major depressive disorder: Comparing remitters and non-remitters to repetitive transcranial magnetic stimulation treatment
- (2021) Hannah Stirton et al. PLoS One
- The anti-inflammatory effects of 15-HETE on osteoarthritis during treadmill exercise
- (2021) Yicheng Tian et al. LIFE SCIENCES
- 5-Lipoxygenase as an emerging target against age-related brain disorders
- (2021) Mengdie Yan et al. AGEING RESEARCH REVIEWS
- Targeted fatty acid metabolomics to discover Parkinson's disease associated metabolic alteration
- (2021) Junjie Zhang et al. JOURNAL OF MASS SPECTROMETRY
- Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
- (2021) Kamil Borkowski et al. Scientific Reports
- Targeted Lipidomic Analysis of Aqueous Humor Reveals Signaling Lipid-Mediated Pathways in Primary Open-Angle Glaucoma
- (2021) Nadezhda V. Azbukina et al. Biology-Basel
- Licofelone, a potent COX/5-LOX inhibitor and a novel option for treatment of neurological disorders
- (2021) Seyed Mehrad Razavi et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- ARGEOS: A New Bioinformatic Tool for Detailed Systematics Search in GEO and ArrayExpress
- (2021) Gleb E. Gavrish et al. Biology-Basel
- Diagnosis and Treatment of Parkinson Disease
- (2020) Melissa J. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Oxylipin Profiles in Plasma of Patients with Wilson’s Disease
- (2020) Nadezhda V. Azbukina et al. Metabolites
- High Glucosylceramides and Low Anandamide Contribute to Sensory Loss and Pain in Parkinson's Disease
- (2020) Katharina Klatt‐Schreiner et al. MOVEMENT DISORDERS
- Aspirin and ibuprofen could lower risk of LRRK2 Parkinson disease
- (2020) Ian Fyfe Nature Reviews Neurology
- Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
- (2020) Marta Pajares et al. Cells
- Inflammation in Dry Eye Syndrome: Identification and Targeting of Oxylipin-Mediated Mechanisms
- (2020) Dmitry V. Chistyakov et al. Biomedicines
- Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
- (2020) Hyuk Sung Kwon et al. Translational Neurodegeneration
- Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease)
- (2019) Dariusz Włodarek Nutrients
- Parkinson's Disease and Parkinsonism
- (2019) Michael T Hayes AMERICAN JOURNAL OF MEDICINE
- Neuroinflammation as a Common Feature of Neurodegenerative Disorders
- (2019) Leonardo Guzman-Martinez et al. Frontiers in Pharmacology
- Oxylipin Profiling of Alzheimer’s Disease in Nondiabetic and Type 2 Diabetic Elderly
- (2019) Jill K. Morris et al. Metabolites
- Lipid peroxidation biomarkers correlation with medial temporal atrophy in early Alzheimer Disease
- (2019) Carmen Peña-Bautista et al. NEUROCHEMISTRY INTERNATIONAL
- Role of oxylipins in cardiovascular diseases
- (2018) Mohammed A Nayeem ACTA PHARMACOLOGICA SINICA
- Astrocytes synthesize primary and cyclopentenone prostaglandins that are negative regulators of their proliferation
- (2018) Dmitry V. Chistyakov et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling
- (2018) Huiyuan Zhao et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Resolution of inflammation and mood disorders
- (2018) Dmiry V. Chistyakov et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Plasma Fatty Acid Lipidomics in Amnestic Mild Cognitive Impairment and Alzheimer's Disease
- (2018) Luigi Iuliano et al. JOURNAL OF ALZHEIMERS DISEASE
- Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease
- (2018) Li Ren et al. MEDICINE
- Effects of anticoagulants and storage conditions on clinical oxylipid levels in human plasma
- (2018) Hulda S. Jonasdottir et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Non-steroidal anti-inflammatory drugs and risk of Parkinson’s disease in the elderly population: a meta-analysis
- (2018) Tahmina Nasrin Poly et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
- (2017) Panchanan Maiti et al. Translational Neurodegeneration
- An update on the diagnosis and treatment of Parkinson disease
- (2016) Philippe Rizek et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
- (2015) Sandeep Vasant More et al. Molecular Neurodegeneration
- Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs
- (2015) Melissa Gabbs et al. Advances in Nutrition
- Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation
- (2014) Anne Barden et al. JOURNAL OF LIPID RESEARCH
- COX-2 in the neurodegenerative process of Parkinson's disease
- (2012) Peter Teismann BIOFACTORS
- Use of ibuprofen and risk of Parkinson disease
- (2011) X. Gao et al. NEUROLOGY
- Cyclooxygenase and Neuroinflammation in Parkinsons Disease Neurodegeneration
- (2010) Anna Bartels et al. Current Neuropharmacology
- Oxidative damage in Parkinson disease: Measurement using accurate biomarkers
- (2009) Raymond C.S. Seet et al. FREE RADICAL BIOLOGY AND MEDICINE
- Thematic Review Series: Proteomics.An integrated omics analysis of eicosanoid biology,
- (2009) Matthew W. Buczynski et al. JOURNAL OF LIPID RESEARCH
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation